Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhiannon David

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Toxicology Research|August 10, 2018
Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acidJames A Akingbasote, Alison J Foster, Huw B Jones, et al.
ALTEX|August 31, 2022
Application of Immunocompetent Microphysiological Systems in Drug Development: Current Perspective and RecommendationsXiaoting Wang, Anna K Kopec, Mark Collinge, et al.
Frontiers in Medicine|September 30, 2021
An Individual Patient's "Body" on Chips-How Organismoid Theory Can Translate Into Your Personal Precision Therapy ApproachUwe Marx, Enrico Accastelli, Rhiannon David, et al.
Frontiers in Endocrinology|May 16, 2020
microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass IndexAlexandra E Butler, Vimal Ramachandran, Thozhukat Sathyapalan, et al.
Biochemical Society Transactions|April 19, 2022
Organ-on-a-chip: current gaps and future directionsPelin L Candarlioglu, Gianni Dal Negro, David Hughes, et al.
Frontiers in Endocrinology|August 28, 2020
Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass IndexAlexandra E Butler, Vimal Ramachandran, Thozhukat Sathyapalan, et al.
Frontiers in Endocrinology|October 26, 2020
Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective StudyAlexandra E Butler, Vimal Ramachandran, Thomas Keith Cunningham, et al.
Drug Discovery Today|March 14, 2025
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessmentJacintha Shenton, Imein Bousnina, Michael Oropallo, et al.
Nature Communications|October 12, 2022
Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitorsDavid B Chou, Brooke A Furlong, Ryan R Posey, et al.
Nature Biomedical Engineering|February 14, 2020
Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiologyDavid B Chou, Viktoras Frismantas, Yuka Milton, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Toxicology Research|August 10, 2018
Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acidJames A Akingbasote, Alison J Foster, Huw B Jones, et al.
ALTEX|August 31, 2022
Application of Immunocompetent Microphysiological Systems in Drug Development: Current Perspective and RecommendationsXiaoting Wang, Anna K Kopec, Mark Collinge, et al.
Frontiers in Medicine|September 30, 2021
An Individual Patient's "Body" on Chips-How Organismoid Theory Can Translate Into Your Personal Precision Therapy ApproachUwe Marx, Enrico Accastelli, Rhiannon David, et al.
Frontiers in Endocrinology|May 16, 2020
microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass IndexAlexandra E Butler, Vimal Ramachandran, Thozhukat Sathyapalan, et al.
Biochemical Society Transactions|April 19, 2022
Organ-on-a-chip: current gaps and future directionsPelin L Candarlioglu, Gianni Dal Negro, David Hughes, et al.
Frontiers in Endocrinology|August 28, 2020
Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass IndexAlexandra E Butler, Vimal Ramachandran, Thozhukat Sathyapalan, et al.
Frontiers in Endocrinology|October 26, 2020
Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective StudyAlexandra E Butler, Vimal Ramachandran, Thomas Keith Cunningham, et al.
Drug Discovery Today|March 14, 2025
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessmentJacintha Shenton, Imein Bousnina, Michael Oropallo, et al.
Nature Communications|October 12, 2022
Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitorsDavid B Chou, Brooke A Furlong, Ryan R Posey, et al.
Nature Biomedical Engineering|February 14, 2020
Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiologyDavid B Chou, Viktoras Frismantas, Yuka Milton, et al.
Pageof 3